Giulia Rastrelli

Dr. Giulia Rastrelli

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2020 in Andrology
Verified
Journal Article
Closed access
PDF file
GRGiulia Rastrelli
Giulia Rastrelli
VSVincenza Di Stasi
Vincenza Di Stasi
FIFrancesco Inglese
Francesco Inglese
MBMassimiliano Beccaria
Massimiliano Beccaria
MGMartina Garuti
Martina Garuti
LVLinda Vignozzi
Linda Vignozzi

13 February 2014 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
GCGiovanni Corona
Giovanni Corona
LVLinda Vignozzi
Linda Vignozzi
GRGiulia Rastrelli
Giulia Rastrelli
Francesco LottiFrancesco Lotti
Francesco Lotti
SCSarah Cipriani
Sarah Cipriani
MMMario Maggi
Mario Maggi
Metabolic syndrome (MetS) is a well-recognized cluster of cardiovascular (CV) risk factors including obesity, hypertension, dyslipidemia, and hyperglycaemia, closely associated with an increased risk of forthcoming cardiovascular disease and type 2 diabetes mellitus. Emerging evidence indicates that benign prostate hyperplasia (BPH) and its related lower urinary tract symptoms (LUTS) represent other clinical conditions frequently observed in subjects with MetS. Several modifiable factors involved in MetS determinism, such as inadequate diet, lack of physical exercise, and smoking and drinking behaviours are emerging as main contributors to the development of BPH. The pathogenetic mechanisms underlying the connection between MetS and BPH have not been completely clarified. MetS and its components, hypogonadism, and prostate inflammation probably play an important role in inducing BPH/LUTS. Although historically considered as a “normal” consequence of the aging process, BPH/LUTS should now be faced proactively, as a preventable disorder of the elderly. Type of diet and level of physical activity are now considered important factors affecting prostate health in the aging male. However, whether physical exercise, weight loss, and modifications of dietary habit can really alter the natural history of BPH/LUTS remains to be determined. Further research is advisable to better clarify these points.

1 January 2020 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
GCGiovanni Corona
Giovanni Corona
GRGiulia Rastrelli
Giulia Rastrelli
Annamaria MorelliAnnamaria Morelli
Annamaria Morelli
ESErica Sarchielli
Erica Sarchielli
SCSarah Cipriani
Sarah Cipriani
MMMario Maggi
Mario Maggi
Corona G, et al. World J Mens Health. 2019 Jan;37:e49. https://doi.org/10.5534/wjmh.190061

Verified
Journal Article
Open access
PDF file
DYDimitri Yannas
Dimitri Yannas
FFFrancesca Frizza
Francesca Frizza
LVLinda Vignozzi
Linda Vignozzi
GCGiovanni Corona
Giovanni Corona
MMMario Maggi
Mario Maggi
GRGiulia Rastrelli
Giulia Rastrelli
Erectile dysfunction (ED) is an early manifestation of cardiovascular (CV) disease. For this reason, men with ED should be carefully assessed for CV risk factors in order to prevent future major adverse CV events (MACE). Traditional risk factors are not found in all subjects at high CV risk. In fact, a relevant proportion of MACE occurs in men who are apparently risk factor free. In men with ED, it is important to take into account not only traditional risk factors but also unconventional ones. Several parameters that derive from good clinical assessment of subjects with ED have proven to be valuable predictors of MACE. These include family history of cardiometabolic events, alcohol abuse, fatherhood, decreased partner’s sexual interest, severe impairment in erection during intercourse or during masturbation, impaired fasting glucose, increased triglycerides, obesity even without metabolic complications, decreased penile blood flows or impaired response to an intra-cavernosal injection test. Recognizing these risk factors may help in identifying, among subjects with ED, those who merit stricter lifestyle or pharmacological interventions to minimize their CV risk. Effective correction of risk factors in ED men considered as high risk, besides reducing CV risk, is also able to improve erectile function.

3 March 2020 in Expert Review of Cardiovascular Therapy
Verified
Journal Article
Closed access
GCGiovanni Corona
Giovanni Corona
GRGiulia Rastrelli
Giulia Rastrelli
AIAm Isidori
Am Isidori
Rosario PivonelloRosario Pivonello
Rosario Pivonello
CBC. Bettocchi
C. Bettocchi
MMMario Maggi
Mario Maggi
Introduction: A large body of evidence has clearly documented that erectile dysfunction (ED) represents not only a complication of cardiovascular (CV) diseases (CVD) but often an early sign of forthcoming CVD. Areas covered: All the available data from meta-analyses evaluating the association between ED and CV risk were collected and discussed. Similarly, all available meta-analyses investigating the significance of ED as a possible early marker for major adverse cardiovascular events (MACE) were analyzed. In addition, data originally obtained in a Florence cohort, dealing with a large series of patients seeking medical care for sexual dysfunction, will be also reported. Expert opinion: Available evidence indicates that ED represents a risk factor of CV mortality and morbidity. Not only conventional CV risk factors but also unconventional ones, derived from a perturbation of the relational and intrapsychic domains of ED, might play a possible role in CV risk stratification of ED subjects. Finally, penile doppler ultrasound can give important information on CV risk, especially in younger and low risk subjects. The presence of ED should become an opportunity – for the patient and for the physician – to screen for the presence of comorbidities improving not only sexual health but, more importantly, men’s overall health.

1 June 2018 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
GRGiulia Rastrelli
Giulia Rastrelli
TOTerence W. O'Neill
Terence W. O'Neill
TATomas Ahern
Tomas Ahern
GBGyörgy Bártfai
György Bártfai
FCFelipe F. Casanueva
Felipe F. Casanueva
TGthe EMAS study group
the EMAS study group